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Abstract. 
 
Mice engineered to express a transgene en-
coding a human Cu/Zn superoxide dismutase (
 
SOD1
 
) 
 
with a Gly
 
93 
 
®
 
 Ala (G93A) mutation found in patients 
who succumb to familial amyotrophic lateral sclerosis 
(FALS) develop a rapidly progressive and fatal motor 
neuron disease (MND) similar to amyotrophic lateral 
sclerosis (ALS). Hallmark ALS lesions such as frag-
mentation of the Golgi apparatus and neurofilament 
(NF)-rich inclusions in surviving spinal cord motor neu-
rons as well as the selective degeneration of this popu-
lation of neurons were also observed in these animals. 
Since the mechanism whereby mutations in 
 
SOD1
 
 lead 
to MND remains enigmatic, we asked whether NF in-
clusions in motor neurons compromise axonal trans-
port during the onset and progression of MND in a line 
 
of mice that contained 
 
z
 
30% fewer copies of the trans-
gene than the original G93A (Gurney et al., 1994). The 
onset of MND was delayed in these mice compared to 
the original G93A mice, but they developed the same 
neuropathologic abnormalities seen in the original 
G93A mice, albeit at a later time point with fewer vacu-
oles and more NF inclusions. Quantitative Western blot 
analyses showed a progressive decrease in the level of 
NF proteins in the L5 ventral roots of G93A mice and a 
concomitant reduction in axon caliber with the onset of 
motor weakness. By 
 
z
 
200 d, both fast and slow axonal 
transports were impaired in the ventral roots of these 
mice coincidental with the appearance of NF inclusions 
and vacuoles in the axons and perikarya of vulnerable 
motor neurons. This is the first demonstration of im-
paired axonal transport in a mouse model of ALS, and 
we infer that similar impairments occur in authentic 
ALS. Based on the temporal correlation of these im-
pairments with the onset of motor weakness and the 
appearance of NF inclusions and vacuoles in vulnerable 
motor neurons, the latter lesions may be the proximal 
cause of motor neuron dysfunction and degeneration in 
the G93A mice and in FALS patients with 
 
SOD1
 
 muta-
tions.
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1. 
 
Abbreviations used in this paper
 
: ALS, amyotrophic lateral sclerosis;
FALS, familial ALS; MND, motor neuron disease; NF, neurofilament;
PD, Parkinson’s disease.
 
N
 
eurofilaments 
 
(NFs)
 
1
 
 comprise the major class
of neuron-specific intermediate filaments and are
the most abundant cytoskeletal components found
in large myelinated axons (for reviews see Nixon, 1993;
Fuchs and Weber, 1994). NFs are heteropolymers formed
by three subunits known as the high (NFH; 110 kD), middle
(NFM; 95 kD), and low (NFL; 62 kD) molecular weight NF
proteins, all of which are synthesized in neuronal perikarya
and transported in the SCa phase (i.e., slow component a)
of axonal transport at 
 
z
 
0.2 to 1.2 mm/d (Lasek and Hoff-
man, 1976). Other cytoskeletal components (e.g., actin, tu-
bulin) are transported three to four times faster in the SCb
of slow axonal transport (Hoffman and Lasek, 1980).
The carboxy termini or tail domains of NFH and NFM
harbor tandem repeats of lysine-serine-proline (KSP) mo-
tifs, and the serine in this motif may be phosphorylated un-
der both physiological and pathological conditions (Jones
and Williams, 1982; Julien and Mushynski, 1982; Black and
Lee, 1988; Lee et al., 1988
 
a
 
,
 
b
 
; Clark and Lee, 1991; Giasson
and Mushynski, 1996). Normally, the serines in these mo-
tifs become highly phosphorylated only after NFH and
NFM have been transported into axons where this phos-
phorylation regulates the caliber of axons (de Waegh et
al., 1992; Cole et al., 1994; Tu et al., 1995). In a variety of
human neurodegenerative diseases, such as amyotrophic
lateral sclerosis (ALS) and Parkinson’s disease (PD), as
well as in neurotoxin-induced neuropathies, such as those
that result from exposure to aluminum and acrylamide
(Troncoso et al., 1985; Yase, 1988; Johnson and Jope,
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1988; Johnson et al., 1990; Strong, 1994), NF inclusions
typically form in the perikarya and processes of neurons,
and these inclusions contain highly phosphorylated NFH
and NFM (Tu et al., 1997
 
a
 
,
 
b
 
). The major functions of NFs
are to provide mechanical support, especially in large my-
elinated axons, and to regulate axonal caliber. Thus, dis-
ruption of the NF network has been hypothesized to play a
mechanistic role in the degeneration of selectively vulner-
able neurons that accumulate inclusions in a subset of hu-
man neurodegenerative disease (Lee et al., 1994; Julien,
1995). Significantly, this hypothesis has been supported by
several recent studies of a number of different lines of
transgenic mice that develop an ALS-like phenotype, in-
cluding prominent NF inclusions in motor neurons that
subsequently degenerate (Côté et al., 1993; Xu et al., 1993;
Eyer and Peterson, 1994; Lee et al., 1994; Tu et al., 1997
 
a
 
).
Since only variations in the number of KSP motifs in NFH
have been observed in some ALS patients (Figlewicz et
al., 1994), other factors may lead to disruption of the NF
network in neurodegenerative disorders. For example,
mutations in the Cu/Zn superoxide dismutase gene (
 
SOD1
 
),
which occurs in 
 
z
 
20% of familial ALS (FALS) kindreds,
lead to perturbations of the NF network (for recent review
see Tu et al., 1997
 
b
 
). FALS (as well as sporadic ALS) is a
motor neuron disease (MND) characterized by progres-
sive motor weakness due to the selective degeneration of
motor neurons, many of which accumulate NF inclusions
before their demise (Schmidt et al., 1987; Hill et al., 1991;
Hirano, 1991; Tu et al., 1997
 
b
 
). Transgenic mice that ex-
press one of four different mutant forms of the human
 
SOD1
 
 gene recapitulate many of the hallmarks of FALS
including a fatal, progressive motor neuron weakness, the
selective loss of motor neurons (Gurney et al., 1994; Ripps
et al., 1995; Wong et al., 1995; Bruijn et al., 1997), fragmen-
tation of the Golgi apparatus (Mourelatos et al., 1996),
and the accumulation of NF inclusions in motor neurons
that are vulnerable to degenerate (Dal Canto and Gurney,
1994, 1995, 1997; Tu et al., 1996). The precise mechanisms
that lead to the selective degeneration of neurons in au-
thentic ALS as well as in transgenic mouse models of this
disorder remain enigmatic, but there is evidence to suggest
that NF inclusions may impede axonal transport and
thereby contribute to the degeneration of affected neu-
rons (Collard et al., 1995). Alternatively, other studies sug-
gest that NF inclusions may compromise the viability of af-
fected neurons by sequestering vital organelles (Tu et al.,
1997
 
a
 
). Thus, the present study exploited a classic experi-
mental paradigm to determine if axonal transport in the
ventral roots was impaired in transgenic mice that ex-
presses human 
 
SOD1
 
 with a Gly
 
93
 
®
 
Ala mutation (G93A)
and develop an ALS-like phenotype.
 
Materials and Methods
 
Experimental Animals
 
Transgenic mice engineered to overexpress mutant (G93A) and wild-type
(N1029) human 
 
SOD1
 
 (Gurney et al., 1994) were purchased from Jackson
Laboratory (Bar Harbor, ME) and maintained as hemizygotes for this
study. Mice were screened by PCR with primers described by Gurney et
al. (1994). All of these animals were bred and reared in a pathogen-free
environment, and the experimental procedures used here were approved
by the University of Pennsylvania.
 
Immunohistochemistry
 
16 G93A mutant 
 
SOD1
 
 transgenic and age-matched control mice (150,
180, 200, and 230 d, 
 
n
 
 
 
5
 
 2/age group) were perfused with 4% paraformal-
dehyde in PBS after being lethally anesthetized by an intraperitoneal in-
jection of ketamine hydrochloride (1 mg/10 g) and xylazine (0.1 mg/10 g).
The spinal cords of these mice were harvested after a postperfusion inter-
val of 2 h, immersed in the same fixative overnight, rinsed in PBS three
times for 10 h, and embedded in paraffin as described (Tu et al., 1997
 
a
 
).
Blocks of spinal cord were cut into 6-
 
m
 
m-thick sections, mounted on poly-
 
l
 
-lysine–coated slides, and heated overnight at 40
 
8
 
C. Every other section
was then examined by immunohistochemical methods using a panel of an-
tibodies to NF and other proteins (Schmidt et al., 1987; Tu et al., 1996,
1997
 
a
 
).
 
Electron Microscopy
 
16 G93A 
 
SOD1
 
 transgenic and age-matched control mice of four different
ages (150, 180, 200, and 230 d, 
 
n
 
 
 
5
 
 2/age group) were deeply anesthetized
as described above and sacrificed by intracardiac perfusion with 10 ml of
0.1 M cacodylate buffer (pH 7.4) and 50 ml of 2% glutaraldehyde and 2%
paraformaldehyde in 0.1 M cacodylate buffer. The L5 segments of the spi-
nal cords of these animals and their corresponding ventral roots were re-
moved, and processed for EM analysis. The ventral horns of the spinal
cords were trimmed to blocks of 
 
z
 
1 mm
 
3
 
 and along with the nerve roots
were postfixed in 1% osmium tetroxide for 20 min. After dehydration
with graded ethanols, the tissue was embedded in Epon-Araldite resin at
60
 
8
 
C for 72 h. Ultrathin sections of these blocks were then cut and
mounted on 100 mesh grids and stained with 1% uranyl acetate and 0.5%
lead citrate. The EM grids were examined using an electron microscope
(100CX; Jeol, Ltd., Tokyo, Japan) at 80 kV.
 
Analysis of Ventral Roots by Quantitative
Western Blotting
 
The ventral roots of 24 G93A 
 
SOD1
 
 and N1029 transgenic mice as well as
age-matched control mice of four different ages (150, 180, 200, and 230 d,
 
n
 
 
 
5
 
 3/age group) were harvested after being lethally anesthetized as de-
scribed above. The L5 segment of the spinal cord was identified after
laminectomy of the T13 to L6 vertebral bodies. It was then harvested and
the attached ventral root was cut into five consecutive 2-mm-long seg-
ments for Western blot analysis (Fig. 1). Each segment was individually
homogenized in 50 
 
m
 
l of BUST buffer (0.5% SDS, 8 M urea, 2% 
 
b
 
-mer-
captoethanol, 0.01% proteinase inhibitor cocktail, and 0.1 M Tris HCl, pH
6.8) as described earlier (Cole et al., 1994; Tu et al., 1995). The solubilized
samples were centrifuged in an ultracentrifuge (TL-100; Beckman Instru-
ments, Inc., Fullerton, CA) for 30 min at 25
 
8
 
C, and 8 
 
m
 
l of supernatant
from each sample (containing 
 
z
 
5 
 
m
 
g of protein) was loaded into individ-
ual lanes of a 6 or 7.5% polyacrylamide gel and separated by SDS-PAGE.
Proteins were then transferred to nitrocellulose membranes for quantita-
tive Western blot analysis as previously described (Cole et al., 1994; Tu et
al., 1995).
The following antibodies were used in this study: (
 
a
 
) polyclonal rabbit
anti-NFH antiserum specific for the carboxy-terminus of NFH (1:500); (
 
b
 
)
RMO24, a mouse mAb to a highly phosphorylated epitope of NFH (1:
1,000); (
 
c
 
) RMO189, a mouse mAb to the rod domain of NFM (1:1,000);
(
 
d
 
) a polyclonal rabbit antiserum specific for the carboxy terminus of NFL
(1:1,000); and (
 
e
 
) a mouse mAb to 
 
b
 
-tubulin (1:200; Sigma Chemical Co.,
St. Louis, MO). The specificity of these antibodies has been well docu-
mented (Tu et al., 1996, 1997
 
a
 
, and references therein) as have the proce-
dures for quantitative Western blotting and statistical analysis of the
Western blot data (Cole et al., 1994; Tu et al., 1995).
 
Axonal Transport Studies
 
24 G93A transgenic and N1029 transgenic mice as well as age-matched
control mice of two different ages (150 and 200 d, 
 
n
 
 
 
5
 
 3/age group) under-
went laminectomy from segments T13 to L1 of the spinal cord under deep
anesthesia. 200 
 
m
 
Ci of 
 
35
 
S-labeled methionine/0.6 
 
m
 
l of saline was microin-
jected into two sites of the L5 ventral horn using a stereotaxic apparatus
over a period of 2 min (Fig. 1) as previously described (Mitsumoto and
Gambetti, 1986; Mitsumoto et al., 1993). Groups of animals were sacri-
ficed 3 h and 7 d after microinjection for the analysis of fast and slow ax-
onal transport, respectively. The L5 ventral roots were removed, pro- 
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cessed for SDS-PAGE, and subjected to quantitative Western blotting as
described above.
 
Neuronal Counting
 
Quantification of ventral horn neurons was performed on spinal cord sam-
ples from the animals perfused for immunohistochemistry and EM as out-
lined above. To do this, 6-
 
m
 
m-thick sections of spinal cord from the L5
segment of three sets of the G93A, N1029, and control mice of four differ-
ent ages (150, 180, 200, and 230 d, 
 
n
 
 
 
5
 
 3/group) were stained with the Nissl
method. Images at 100
 
3
 
 magnification were captured to the computer
from slides using the NIH Image software (version 5.4). Only ventral horn
neurons with clear nucleoli were counted in 10 different sections from
each spinal cord. These sections were separated from each other by 30 
 
m
 
m
to avoid repetitive counting. Data were analyzed statistically using a Stu-
dent’s 
 
t
 
 test.
 
Axonal Counting
 
The toluidine blue–stained semithin sections that were used to count ax-
ons in the L5 ventral roots came from three sets of the G93A, N1029, and
control mice at 150, 180, 200, and 230 d of age that were prepared for the
EM and immunocytochemical studies described above. To quantify the
number of axons in these nerves, toluidine blue–stained transverse sec-
tions of L5 ventral roots were captured with Northern Exposure software
(Empix Imaging Inc., Glen Mills, PA), and then printed at 400
 
3
 
 magnifi-
cation. An 8 
 
3
 
 11 inch template transparency composed of identical
squares was overlaid on the photograph to facilitate counting axons in
each ventral root. The number of axons in each square was counted and
pooled together to generate the total number of axons in a ventral root,
and the data were analyzed statistically using a Student’s 
 
t
 
 test.
 
Results
 
The Onset of MND Is Delayed in Rederived G93A 
Transgenic Mice with a Lower Copy Number of the 
Mutant SOD1 Gene
 
The G93A mutant and wild-type (N1029) 
 
SOD1
 
 trans-
genic mice used in this study were purchased from Jackson
Laboratory and were rederived from the original G93A
and the N1029 transgenic mice generated by Gurney et al.
(1994). However, for unknown reasons, the rederived
G93A mice contain 30% fewer copies of the 
 
SOD1
 
 trans-
gene than the original G93A transgenic mice (this infor-
mation is now posted on the Web page of Jackson Labora-
tory), and these mice develop an ALS-like phenotype later
than the original line of mice. For example, muscle weak-
ness and retraction of the hindlimbs with tail suspension
were not observed in the rederived G93A mice until 
 
z
 
200
 
6
 
 7 d of age, while the original mice become weak at 
 
z
 
120 d
(Gurney et al., 1994). Further, the rederived G93A mice
were completely paralyzed at 
 
z
 
250 d, rather than at 150 d,
as in the original line. The rederived N1029 mice that over
express wild-type 
 
SOD1
 
 transgene do not show evidence
of MND for up to 2 yr just like the original line of these
mice (Gurney et al., 1994; Tu et al., 1996).
 
NF Inclusions Occur in Spinal Cord Motor Neurons of 
the Rederived G93A Transgenic Mice
 
We compared the extent of NF inclusions stained by he-
matoxylin and eosin (H&E) in spinal cord motor neurons
of the rederived G93A transgenic mice with the orginal
G93A mice and demonstrated Lewy body–like inclusions
in the perikarya and proximal axons of spinal cord moto-
neurons by 
 
z
 
180 d of age (data not shown). Immunohis-
tochemical studies performed with NF subunit-specific an-
tibodies (e.g., RMO32 specific for highly phosphorylated
NFM, RMO24 specific for highly phosphorylated NFH,
and rabbit anti-NFL polyclonal antiserum) showed that
these inclusions contained immunoreactivity for all three
NF proteins (Fig. 2 and data not shown). The number of
these NF-rich inclusions increased with the age, and vacu-
oles were seen in many of these neurons, although they
were much less prominent than in the original G93A mice
of the same stage of MND (Fig. 2, 
 
A
 
 and 
 
B
 
, compare ar-
rowheads). This is in agreement with a recent study, which
demonstrated little or no vacuolar pathology in a line of
G93A mice with very low transgene copy numbers and an at-
tenuated (400 d) onset of an ALS-like phenotype (Dal
Canto and Gurney, 1997). Interestingly, RMdO9 (a mAb
Figure 1. Schematic diagram
showing the microdissection
of L5 ventral roots and the
microinjection of [35S]me-
thionine into the ventral
horn of the mouse spinal
cord in the experimental par-
adigm used here to analyze
axonal transport.
Figure 2. Photomicrographs showing NF-rich inclusions in the
perikarya and proximal axons of the spinal cord of the G93A
mice. The NF inclusions contain NFL epitopes revealed by a rab-
bit anti-NFL polyclonal antiserum (A and B). Notably, the vacu-
olar pathology (arrowheads) in the rederived G93A mice in the
terminal stages of MND (230 d of age in B) is less prominent than
in the original line of G93A mice at a similar terminal stage (140 d
of age in A). However, the inclusions (arrows) in the rederived
G93A mice in the terminal stages of MND (230 d of age in B) are
more abundant than in the original line of G93A mice at a similar
terminal stage (140 d of age in A). The large arrow in B indicates
an inclusion with light staining. In C and D, the RMdO9 mAb to
poorly phosphorylated NFH stains the white matter of the spinal
cord of the G93A mouse (D) more intensely than in the control
mouse (C), and the small arrows in D indicate RMdO9-stained
axonal inclusions containing poorly phosphorylated NFH. Bars:
(B) 20 mm; (D) 40 mm. 
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specific for a non- or poorly phosphorylated NFH epitope),
intensively stained axons in the white matter of the spinal
cords of the G93A mice (Fig. 2 
 
D
 
), but this mAb stained
the same region of control mice very weakly (Fig. 2 
 
C
 
),
suggesting that the phosphorylation state of NFH in white
matter axons of the G93A mice may be markedly reduced.
 
Ultrastructural Changes in the Rederived G93A 
Transgenic Mice
 
Since NF inclusions were detected in neuronal perikarya
and axons of G93A mice, we compared the ultrastructural
changes of NF morphology in proximal axons and ventral
roots of G93A and control mice. NFs were aligned in par-
allel in the normal proximal axons (Fig. 3 
 
A
 
), but masses
of tightly packed, disoriented filaments similar to NFs
were detected in proximal axons of the G93A mice (Fig. 3
 
B
 
). These inclusions resembled the spheroids seen in hu-
man ALS (Gurney et al., 1994; Tu et al., 1995) as well as in
transgenic mice that over express NF proteins and develop
MND (Côté et al., 1993; Xu et al., 1993; Lee et al., 1994;
Wong et al., 1995; Tu et al., 1997
 
a
 
). Aggregates of dilated
mitochondria and other organelles also were seen proxi-
mal to these inclusions in some axons (data not shown).
Notably, the number of normal NFs in the L5 ventral root
axons of the rederived G93A mice was dramatically re-
duced (Fig. 3 
 
D
 
) at 200 d compared to age-matched con-
trol mice (Fig. 3 
 
C
 
), but the thickness of the myelin sheath
around large axons appeared similar in the ventral roots of
the G93A and age-matched control mice.
 
NF Triplet Proteins and Tubulin Are Reduced in the 
Ventral Root Axons of the Rederived G93A Mice
 
Since NF inclusions are found in proximal axons of the
G93A mice and the number of NFs in the ventral roots of
these mice are reduced, we asked whether or not the
amount of NF subunit proteins was reduced in the G93A
mice. To do this, we performed quantitative Western blot
analysis on 2-mm segments along the ventral roots of the
G93A and N1029 transgenic mice as well as control mice
to compare the relative levels of the NF triplet proteins in
the ventral root axons (see Fig. 1 for orientation). At 150 d,
the levels of NF proteins in the L5 ventral root axons of
the G93A mice were similar to N1029 and control mice
(Fig. 4, A and E), but there were no NF inclusions or mo-
tor neuron degeneration at this time in the G93A mice
(data not shown). However, by 180 d, a substantial de-
crease in NF proteins was detected in the G93A mice com-
pared to age-matched N1029 and the control mice (Fig. 4,
B and E). Specifically, a 50% decrease in NFL was first de-
tected in 180-d-old G93A mice (Fig. 4, B and E), and the
levels of NFL decreased progressively by 70 and 90%
when these mice were 200 (Fig. 5, C and E) and 230 d of
age (Fig. 4, D and E), respectively. An obvious decrease in
the NFM immunoreactivity also was observed in the ven-
tral root axons of the G93A mice, although it occurred
slightly later and to a lesser extent than the decrease in
NFL. For example, the levels of NFM were reduced by 50
and 70% when the G93A mice were 200 and 230 d of age,
respectively. Similarly, the levels of NFH in the ventral
root axons of the G93A mice decreased at 200 and 230 d of
age by 90 and 95%, respectively (Fig. 4 E). Since the de-
crease in the levels of NF proteins was similar in all five
consecutive segments of the ventral roots of the G93A
mice, this suggests that orthograde transport of NF pro-
teins may be retarded at one or more sites proximal to the
ventral root axons studied here. Our analysis also showed
that the amount of NF proteins in the ventral root axons of
the N1029 transgenic mice was comparable to that seen in
the ventral root axons of the control mice at all four ages
examined here (data not shown). Thus, both the N1029
transgenic and the wild-type littermates of G93A mice were
used as controls and are referred to as such together here.
To determine if the levels of NF proteins were reduced
selectively in ventral root axons of the G93A mice, b-tubu-
lin levels were analyzed in the same ventral root samples
using the methods outlined above. As shown in Fig. 4, the
levels of b-tubulin in the ventral root axons of the N1029
transgenic mice were similar to those in the control mice at
150 d (Fig. 4 A). However, like NF proteins, the b-tubulin
levels in the ventral root axons of the G93A mice de-
Figure 3. Electron micrographs showing NF accumulations in a
proximal axon of a spinal cord motor neuron and reduced NFs in
an L5 ventral root of a 200-d-old G93A mouse. NFs are aligned in
parallel in the normal axon (A). The NF inclusion is a mass of
tightly packed disorganized NFs (B). This inclusion fills the axon
and displaces cellular organelles in the proximal ventral root ax-
ons of the G93A mice. Normal NFs are shown in a cross-section
of a ventral root axon from a control mouse (C), while there is a
decreased density of NFs in the L5 ventral root axon of G93A
mice (D). Bars: (B) 1 mm; (B, inset, and D) 0.5 mm.Zhang et al. Blocked Axonal Transport in G93A SOD1 Mutant Mice 1311
creased progressively with age. For example, a 20% de-
crease in the levels of b-tubulin was first detected at 180 d
in the ventral root axons of the G93A mice (Fig. 5, B and
E). Further, this decrease progressed to 50 and 70% of the
control values by 200 or 230 d, respectively, in the G93A
mice (Figs. 5 C and 4, D and E). Since the decrease in b-tubu-
lin levels in the ventral root axons of G93A mice also was
observed in all of the ventral segments examined here,
these findings support the hypothesis that axonal transport
of b-tubulin also is impeded proximal to the ventral root.
Taken together, our data suggest that the translocation of
multiple proteins is affected in axons of spinal cord motor
neurons of the G93A mice.
The Decreased Level of NF Proteins Is Not Due to the 
Loss of Ventral Root Axons in Rederived G93A Mice
To determine if the decrease in NF proteins in the ventral
root axons of the G93A transgenic mice resulted exclu-
sively from the loss of axons, we determined the number
of axons in the L5 ventral roots as well as the number of
neurons in the L5 ventral horn from three pairs of control
and G93A transgenic mice at 150, 180, 200, and 230 d of
age. At 150 and 180 d of age, the number of neurons in the
L5 ventral horns of the G93A mice was comparable to that
of age-matched control mice (Table I). Similarly, the num-
ber of axons in the L5 ventral roots of the G93A mice was
not significantly different from that of the age-matched
control mice (Table I and Fig. 5, A and B). However, there
was a z15% decrease in the number of L5 ventral root ax-
ons as well as in the number of the ventral horn neurons in
the G93A mice at 200 d, and by 230 d of age, the numbers
of these axons and neurons were reduced by z25% (Table
I and Fig. 5, C–F). Furthermore, the L5 ventral roots of
the G93A mice at 200 d appeared shrunken and disorien-
tated suggesting that the content of the ventral root axons
may be reduced (compare Fig. 5, C and E with D and F).
Since the magnitude of the reduction in the levels of NF
proteins exceeds the extent of axon loss by two to three
times in the ventral roots of the G93A transgenic mice, we
infer that the progressive diminution in the levels of NF
proteins in L5 ventral root axons is caused by mechanisms
other than axon loss in the G93A mice.
Orthograde Slow Axonal Transport of Cytoskeletal 
Proteins Is Retarded in the Ventral Root Axons of the 
G93A Mice
The accumulation of NFs in proximal axons has been im-
plicated in the retardation of axonal transport in various
experimental paradigms (Griffin et al., 1982; Troncoso et
al., 1985; Collard et al., 1995), and it is speculated that this
may lead to the degeneration of affected axons and their
corresponding neurons (Collard et al., 1995). Since NF-rich
spheroids in the proximal axons of motor neurons and the
reduction of NF proteins in the ventral roots of G93A
transgenic mice suggest that impaired axonal transport
could lead to the MND phenotype, we monitored the
transport of cytoskeletal proteins in the slow component
at 7 d after microinjection of 35S-labeled methionine into
the L5 ventral horns of G93A, N1029, and control mice.
Radiolabeled cytoskeletal proteins traveling in slow axonal
transport components were monitored in 2-mm segments
along the entire length of the ventral roots by SDS-PAGE
(see Fig. 1 for orientation), and the identity of several cy-
Figure 4. Western blots showing a progressive decrease in the
level of NF proteins in the L5 ventral roots of the G93A trans-
genic mice. The ventral roots of 24 G93A SOD1 and N1029
transgenic mice as well as age-matched control mice of four dif-
ferent ages (150, 180, 200, and 230 d, n 5 3/age group) were har-
vested after lethal anesthesia as described. The relative levels of
NFH are revealed by a rabbit anti-NFH polyclonal antiserum;
those of NFM, by the mAb RMO189, and those of NFL, by the
rabbit anti-NFL polyclonal antiserum. The levels of NF proteins
and tubulin in the 150-d-old G93A mouse are comparable to that
of the age-matched control mouse (A, CTR). However, there is a
progressive decrease in NF proteins and tubulin in the ventral
roots of the G93A mice at 180, 200, and 230 d of age compared
with the age-matched CTR mice (B–D). Quantification of these
data (E) shows that NFL and tubulin start to decrease in the
G93A mice as early as 180 d, while a significant reduction in the
levels of NFM, NFH, and tubulin occurs when the G93A mice
reach 200 d of age. The ventral roots of the G93A mice lose 80–
90% of NF proteins when they are at the terminal stages of MND
(230 d). vr1-5, Ventral root segments from 1 to 5; *P , 0.05; **P
, 0.01.
Table I. Number of Ventral Motorneurons and Ventral
Root Axons
Age groups n Number of neurons Number of axons
150 Ctr 3 92.10 6 1.13 869.00 6 61.16
G93A 3 86.65 6 3.75 860.67 6 60.41
180 Ctr 3 87.60 6 2.15 890.33 6 56.88
G93A 3 86.13 6 2.40 881.00 6 52.25
200 Ctr 3 92.62 6 3.18 871.33 6 17.37
G93A 3 85.73 6 1.53 755.33 6 29.63
230 Ctr 3 95.52 6 5.76 873.33 6 51.54
G93A 3 72.48 6 5.71** 651.00 6 49.22**
Table I indicates the number of ventral motor neuons and L5 ventral root axons in
G93A versus control (Ctr) at 150 to 230 d of age.
6, SE.
**, P , 0.01.The Journal of Cell Biology, Volume 139, 1997 1312
tokeletal proteins was determined by Western blots (Fig.
6, A and B). This showed there was no reduction in the in-
tensity of any of the radiolabeled proteins traveling along
the ventral roots by slow axonal transport in 150-d-old
G93A transgenic compared to control mice (Fig. 6 A). For
example, the ratio of the radioactivity of each of the NF
subunit proteins, tubulin subunits, and actin between 150-
d-old G93A and control mice was close to one, suggesting
that there was no difference in the slow axonal transport
of these mice (Fig. 6, A and C–E). By contrast, the move-
ment of these cytoskeletal proteins was considerably re-
duced in the 200-d-old G93A mice (Fig. 6 B). Quantitative
analysis showed that the transport of these proteins was
retarded mainly in the most proximal segment of the ven-
tral roots (Fig. 6, D and E). The transport of NFH and
NFM proteins in the distal ventral root of 200-d-old G93A
mice decreased by 30%, and the transport of NFL was re-
duced by z50% in these mice compared to controls (Fig. 6,
C and D). Significantly, the impairment of axonal transport
in motor neurons of G93A transgenic mice was not limited
to NF proteins. As shown in Fig. 6, B and E, 200-d-old G93A
mice exhibited a 50% reduction in tubulin and actin trans-
port, i.e., two major cytoskeletal proteins of slow axonal
transport. Thus, our data suggest that there are defects in
the slow axonal transport of NF proteins as well as of other
proteins including tubulin and actin in the G93A mice.
Components of Orthograde Fast Axonal Transport
Are Selectively Retarded in the Ventral Root Axons of 
the G93A Mice
Since all major cytoskeletal components of slow axonal
transport were reduced in G93A mice that developed
MND, we asked whether proteins transported in the fast
components also are impaired. To do this, we analyzed ra-
diolabeled proteins at 3 h after microinjection of 35S-labeled
Figure 6. SDS-PAGE shows a progressive retardation in slow
transport in the L5 ventral root of the spinal cord in the G93A
transgenic mice compared to the control (CTR) mice. 12 G93A
and N1029 transgenic mice as well as age-matched control mice
of two different ages (150 and 200 d, n 5 3/age group) were killed
7 d after microinjection. Fluorographs show a decrease in the
transport of a variety of cytoskeletal proteins such as NFH,
NFM, NFL, tubulin, and actin in the 200-d-old G93A mice (B)
but not in the 150-d-old G93A mice (A). The graphs in C and D
illustrate quantitative measurements of individual proteins con-
veyed by slow axonal transport in pairs of age-matched G93A
and CTR mice. The 150-d-old G93A mice fail to show any signif-
icant retardation of slow transport (C). However, the slow trans-
port of several proteins is retarded in the 200-d-old G93A mice
(D). The symbols to the right of each fluorograph in A and B are
aligned with the respective proteins identified on the left, and they
are used in C through E. Tub, Tubulin; Act, actin.
Figure 5. EM photomicrographs show a drastic reduction in the
axonal caliber of the L5 ventral roots of the G93A transgenic
mice by 200 d of age. The ventral roots of the control mouse (A,
C, and E) contain many large myelinated axons that are tightly
packed and evenly distributed in the nerve. Note the relative
abundance of small- and intermediate-sized axons (A, C, and E).
There is no obvious difference in the ventral roots of the G93A
transgenic mice (B) compared to control mice (A) at 150 d. In con-
trast, the ventral roots of the G93A mouse are mainly composed
of axons of smaller caliber (D and F) compared to age-matched
control mice (C and E). The abundant interaxonal space and the
tangential or longitudinal orientation of axons probably reflects
the collapse of these axons due to impaired transport. Bars: (A) 20
mm; (F) 10 mm.Zhang et al. Blocked Axonal Transport in G93A SOD1 Mutant Mice 1313
methionine into the L5 ventral horn of G93A, N1029, and
control mice, and we showed that there was no reduction
in the intensity of any of the radiolabeled proteins traveling
along the ventral roots by fast axonal transport in 150-d-old
G93A and control mice (Fig. 7 A). For example, we com-
pared the ratio of three different radiolabeled proteins
with molecular mass 100, 43, and 20 kD from G93A mice
versus control mice and demonstrated that their move-
ment along all five segments of the ventral roots did not
differ significantly (Fig. 7, A and C). In contrast, the fast
axonal transport of radiolabeled proteins in 200-d-old
G93A mice appeared to be variable when compared to
control mice of the same age (Fig. 7 B). For example, the
migration of a radiolabeled protein with molecular mass
100 kD (Fig. 7 B) was similar to that of the control, and the
transport of a second 43-kD protein was only slightly af-
fected (Fig. 7 B) while the movement of a third 20-kD pro-
tein (Fig. 7 B) was reduced by 60% in the ventral root of
G95A transgenic mice compared to controls, indicating a
selective retardation of specific proteins (Fig. 7, B and D).
Discussion
Several lines of transgenic mice carrying human or mouse
SOD1 transgenes with mutations identified in FALS pa-
tients have been shown to develop an MND phenotype
similar to FALS, and these mice serve as useful animal
models for research into the pathobiology of FALS and
sporadic ALS (for recent review see Tu et al., 1997b). For
example, the G93A transgenic mice used in this study,
which were rederived from the original line generated by
Gurney et al. (1994), develop the cardinal features of hu-
man ALS. However, the transgene copy number in the re-
derived G93A mice is 30% lower than in the original
G93A line, and this significantly affects several key aspects
of the MND phenotype in these mice. For example, the
onset of MND was delayed by 80 d, and the duration of
MND was prolonged by 20 d in the rederived mice com-
pared to the original G93A line. Further, the initial ap-
pearance of vacuoles and NF-rich inclusions also occurred
later in the life span of the rederived G93A mice. Addi-
tionally, the number of vacuoles was decreased, while the
NF-rich inclusions were more abundant in both perikarya
and proximal axons of spinal cord motoneurons. These ob-
servations are in agreement with a recent report demon-
strating that another line of G93A transgenic mice with a
low transgene copy number did not develop MND until
400 d of age (Dal Canto and Gurney, 1997). Significantly,
these mice showed almost no vacuoles, but they had many
more NF-rich inclusions in their spinal cord motor neu-
rons. Taken together, these data clearly demonstrate a di-
rect correlation between the expression levels of the mu-
tant transgene, the age at which MND first emerges, and
the severity or rate of progression of MND. Thus, increas-
ing levels of the mutated gene correlates with an earlier
onset of MND, more abundant vacuoles, and less promi-
nent NF-rich inclusions (Wong et al., 1995; Tu et al., 1996;
Dal Canto and Gurney, 1997).
Since mice carrying the murine equivalent of the human
G85R SOD1 mutation or low copy numbers of the G93A
mutant human SOD1 transgene develop MND, but far
fewer mitochondrial vacuoles, it is likely that NF-rich in-
clusions are the proximal cause of MND. This view is com-
patible with reports that similar vacuoles have not been
detected in FALS patients with a G93A mutation in the
SOD1 gene, and that patients with FALS develop promi-
nent NF-rich inclusions in their surviving spinal motor
neurons with very little, if any, vacuolar pathology (Kato
et al., 1996). Thus, we conclude that the mice with low
copy numbers of a G93A SOD1 transgene are much more
authentic models for FALS than mice with high mutant
transgene copy numbers, and that NF-rich inclusions may
play a causal role in the onset and progression of FALS.
Accordingly, we sought to identify any potentially detri-
mental consequences induced by these NF-rich inclusions.
Here, we report significant decreases in both the levels
and transport rates of NF and other proteins in the L5 ven-
tral roots of aged G93A transgenic mice, and we speculate
that this impaired axonal transport is a consequence of the
accumulation of NF-rich inclusions. Thus, the accumulation
of these inclusions may be the proximal cause of the demise
of spinal cord motor neurons in these mice as well as in ALS.
Although the G93A transgenic mice develop a clinical
and pathologic phenotype similar to FALS and sporadic
ALS (Gurney et al., 1994), the mechanism whereby SOD1
Figure 7. SDS-PAGE shows a progressive retardation in fast
transport in the L5 ventral roots of the spinal cord in the G93A
transgenic mice compared to the control (CTR) mice. 12 G93A
and N1029 transgenic mice as well as age-matched control mice
of two different ages (150 and 200 d, n 5 3/age group) were killed
3 h after microinjection. Fluorographs show no change in the fast
transport of several proteins (closed triangle, closed square, and
closed circle) in the 150-d-old G93A mice (A and C), but the fast
transport of some proteins is retarded in the 200-d-old G93A
mice (B and D). The graphs in C and D illustrate quantitative
measurements of individual proteins conveyed by fast axonal
transport in pairs of age-matched G93A and CTR mice. The 150-d-
old G93A mice fail to show any significant slowing of fast trans-
port (C), but the fast transport of several proteins is retarded in
the 200-d-old G93A mice (D). The symbols in A and B corre-
spond to proteins analyzed in the graphs in C and D.The Journal of Cell Biology, Volume 139, 1997 1314
mutations cause the formation of NF-rich spheroids and
Lewy body–like inclusions in spinal cord motor neurons
remains unknown (Tu et al., 1996). SOD1 is a member of
the SOD gene family, and it is found in the cytosol and
peroxisomes of most cells including neurons (Bannister et
al., 1987; Beyer et al., 1991). The function of SOD1 is to
convert the toxic superoxide anion radical O2
2 to H2O2
(Coyle and Puttfarcken, 1993; Olanow, 1993) which is fur-
ther reduced to H2O by glutathione peroxide and/or cata-
lase. Since normal levels of SOD1 in neurons are neces-
sary for antioxidant defense mechanisms, previous studies
have shown that an imbalance of SOD1 activity can induce
the accumulation of excess amounts of O2
2 or other free
radicals resulting in oxidative damage to neurons (Coyle
and Puttfarcken, 1993; Olanow, 1993). This oxidative
stress may directly or indirectly lead to a retardation in ax-
onal transport resulting in the formation of NF aggregates
in the proximal axons of motor neurons. Alternatively,
since a gain of adverse function has been hypothesized for
the mutant SOD1 gene (Gurney et al., 1994), it is possible
that the NF abnormalities are a direct consequence of this
yet to be identified adverse function.
A slight reduction in the NF levels was detected in the
G93A mice at the onset of MND at 180 d of age, and the
level of NF proteins progressively dropped to only 10 to
20% of the levels seen in age-matched control mice by the
time the G93A mice were completely paralyzed at 230 d of
age. At the same time, a prominent increase in the staining
intensity of RMdO9 was noted in the white matter of the
spinal cords of the G93A mice when compared with age-
matched controls. Since this mAb is specific for poorly
phosphorylated NFH epitopes, this observation indicates
that the phosphorylation state of axonal NFH also is re-
duced in the G93A mice.
NFs are the most important determinants of axonal cali-
ber, but previous studies have shown that Schwann cells
also regulate axonal caliber by modulating the number of
NFs and the phosphorylation state of NFH and NFM (de
Waegh et al., 1992; Cole et al., 1994; Tu et al., 1995), Thus,
a reduction in the level of NF proteins and the phosphory-
lation state of NFH and NFM results in a contraction in
the diameter of affected axons. Notably, the decrease in
NF proteins correlates closely in time with shrinkage of the
axons in the ventral roots and the appearance of clinical
MND in the G93A mice. Since axons that become devoid of
cytoskeletal structures are prone to degenerate (Côté et al.,
1993; Xu et al., 1993; Eyer and Peterson, 1994; Lee et al.,
1994), and axonal degeneration may play a vital role in the
emergence of disease (Sagot et al., 1996), our data suggest
that the loss of NF proteins could lead to the shrinkage and
degeneration of the ventral roots, which may in turn con-
tribute to the onset of MND in the G93A transgenic mice.
There are three probable mechanisms that may explain
the depletion of NFs in the ventral roots of the G93A
mice. The first mechanism is the formation of NF-rich in-
clusions which can retain NF subunits in the perikarya and
proximal axons, thereby reducing the amount of NFs
transported into the distal axons. Interestingly, NFL de-
creased by 50% as early as 180 d of age, whereas NFH and
NFM decreased to the same extent later than NFL. This
differential decrease may be related to the different roles
of these NF triplet proteins. Since NFL forms the back-
bone of NFs (for review see Nixon, 1993), the earlier de-
crease in NFL may be caused by the preferential incorpo-
ration of NFL into inclusions followed by NFM and NFH.
Although the mechanism responsible for the transport of
NF subunit proteins is not clear, specific motor protein(s)
may be involved. It is likely that mitochondrial damage
due to the G93A mutation in these mice may lead to an
energy shortage for these putative NF motor proteins re-
sulting in the failure to transport NF proteins into axons,
thereby causing deposition of assembled NF proteins in
abnormal loci such as perikarya and proximal axons. Also,
FALS mutations in the SOD1 gene have been shown to
convert the protein product of this gene from a free radical
scavenger to an oxidative stressor. This gain of adverse
function by the mutant SOD protein may alter the behav-
ior of NF proteins and lead to the formation of inclusions
(for detailed review see Tu et al., 1997b). However, the
level of tubulin in the ventral roots also decreases, suggest-
ing that factors other than NF inclusions also contribute to
the reduction of proteins in the ventral roots.
A second mechanism to consider is a physical blockage
of axonal transport by these NF inclusions. EM studies
showed that the proximal axons of the G93A mice fre-
quently were dilated by aggregated vacuoles and filamen-
tous inclusions with cellular organelles such as mitochon-
dria clustered at one side of the aggregates. These data
suggest that the axonal transport of organelles could be
blocked by these inclusions. The observation that NF as
well as other proteins (e.g., tubulin) are diminished in the
ventral roots is also consistent with a nonselective mecha-
nism due to a physical blockage of axonal transport. In-
deed, our transport studies showed that the movement of
three NF proteins and other cytoskeletal components such
as tubulin and actin in the ventral roots of the 200-d-old
G93A mice all were retarded. Furthermore, transport of
some of the radiolabeled proteins in the fast phase also was
retarded in the same G93A mice. Currently it is unclear
why some but not all proteins transported by fast axonal
transport are retarded. It is possible that proteins in larger
organelles, such as those found within mitochondria, are
selectively blocked. Since the transport of these proteins in
the fast and slow components involves a complex motor
machinery, the most reasonable explanation for these ob-
servations is a physical blockage of axonal transport by
NF-rich inclusions and aggregated vacuoles at the level of
proximal axons. Finally, a third mechanism involved here
may be reduced NF protein synthesis in the affected motor
neurons, resulting in the diminished export of NF proteins
into their axons. However, additional studies are needed
to address the validity of these hypothetical mechanisms.
In conclusion, our data demonstrate that mutations in
the SOD1 gene lead to an alteration in the NF network,
which may impede both fast and slow axonal transport in
affected spiral cord motor neurons. Thus, our data support
a causal role of NF inclusions in the demise of spinal cord
motor neurons. In view of the striking similarity in the
MND phenotype of these mice and human FALS patients,
this mechanism may be highly relevant to the death of the
same neuronal populations in human FALS.
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